Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Charles River Laboratories is a leading global contract research organization (CRO) and a partner in preclinical research. The company comprehensively supports pharmaceutical and biotech clients in drug development, from discovery to manufacturing. It provides critical laboratory services and animal models to accelerate therapeutic advancements and ensure the safe market launch of new medicines.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Charles River Laboratories is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Charles River Laboratories last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 3.02 USD.
Across its last 3 earnings reports, Charles River Laboratories stock moved by ±2% on average the following day. The largest reaction was -5.7% on 11/05/2025; 0 of 3 reactions were positive.
Charles River Laboratories has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.